# Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC

> **NCT03769805** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 83 (estimated)

## Conditions studied

- Nonsmall Cell Lung Cancer

## Interventions

- **DRUG:** Anlotinib

## Key facts

- **NCT ID:** NCT03769805
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-15
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 83 (ESTIMATED)
- **Last updated:** 2019-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769805, "Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03769805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*